The Effects of Mercaptopurine on Pulmonary Vascular Resistance and BMPR2 Expression in Pulmonary Arterial Hypertension

Am J Respir Crit Care Med. 2020 Jul 15;202(2):296-299. doi: 10.1164/rccm.202003-0473LE.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Antihypertensive Agents / therapeutic use*
  • Bone Morphogenetic Protein Receptors, Type II / drug effects*
  • Bone Morphogenetic Protein Receptors, Type II / genetics*
  • Female
  • Humans
  • Male
  • Mercaptopurine / therapeutic use*
  • Middle Aged
  • Pulmonary Arterial Hypertension / diagnosis*
  • Pulmonary Arterial Hypertension / drug therapy*
  • Vascular Resistance / drug effects*

Substances

  • Antihypertensive Agents
  • Mercaptopurine
  • BMPR2 protein, human
  • Bone Morphogenetic Protein Receptors, Type II